Amarantus Bioscience Holdings Inc (AMBS)

[GS1]

Any product in developement stage is first tested for quality and not quantity and Lympro is tested for stable and consistent results with different types of patients. Also during developement phase they have to perform different types of tests (stimulation levels, incubation times) to tune assay performance. They have to establish these guidelines before full commercialization of product.Once guidelines are established and assay parameters are tuned it will become easier to test in large number of patients.


All I care about is sensitivity, that is what Big Pharma wants. In recent LP-002 study they have improved sensitivity to 90% which is fantastic.

$$$AMBS$$$